z-logo
Premium
Secukinumab decreases serum Krebs von den Lungen 6 ( KL ‐6) level in patients with psoriasis with elevated serum KL ‐6 level
Author(s) -
Chijiwa C.,
Takeoka S.,
Kamata M.,
Uchida H.,
Fukaya S.,
Hayashi K.,
Fukuyasu A.,
Tanaka T.,
Ishikawa T.,
Ohnishi T.,
Tada Y.
Publication year - 2018
Publication title -
british journal of dermatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.16993
Subject(s) - secukinumab , medicine , psoriasis , gastroenterology , dermatology , psoriatic arthritis

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom